Verona Pharma plc
Salt of a pyrimido[6,1-A]isoquinolin-4-one compound

Last updated:

Abstract:

The present invention relates to a pharmaceutically acceptable acid addition salt of: (i) 9,10-dimethoxy-2-(2,4,6-trimethylphenylimino)-3-(N-carbamoyl-2-aminoethyl- )-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one (RPL554); and (ii) ethane-1,2-disulfonic acid, ethanesulfonic acid, methanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, hydrochloric acid, hydrobromic acid, phosphoric acid or sulfuric acid.

Status:
Grant
Type:

Utility

Filling date:

10 Feb 2016

Issue date:

5 Nov 2019